| | | | |
| Please limit public testimony to 3 minutes. The public is also welcome to |
|
| submit copies of written testimony to the Committee. |
|
|
| | | | |
| | Relating to health care-associated infection rates at certain health care facilities and the creation of an advisory panel. |
|
|
|
|
| | | | |
| | Relating to the disclosure of certain economic benefits provided by manufacturers or repackagers of prescription drugs; providing penalties. |
|
|
|
|
| | | | |
| | Relating to health benefit plan coverage for enrollees with autism spectrum disorder. |
|
|
|
|
| | | | |
| | Relating to the distribution, possession, purchase, consumption, and receipt of tobacco products. |
|
|
|
|
| | | | |
| | Relating to the child fatality review process, including the composition and functions of the child fatality review committee. |
|
|
|
|
| | | | |
| | Relating to environmental lead investigations by the Department of State Health Services. |
|
|
|
|
| | | | |
| | Relating to the screening of newborns for sickle cell trait by the Department of State Health Services. |
|
|
|
|
| | | | |
| | Relating to nursing peer review and the regulation of the practice of nursing. |
|
|
|
|
| | | | |
| | Relating to prescriptions for certain controlled substances. |
|
|
|
|
| | | | |
| | Urging the Texas congressional delegation to support legislation to expand telemedicine/telehealth services. |
|
|
|
|